Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Alternative gene ends: the crosstalk of RNA cleavage and transcription termination

Project description

Gene expression regulation: the role of RNA cleavage

For a gene to be translated into protein, the intermediate messenger RNA must be correctly processed. This involves the process of 3’ end cleavage and polyadenylation, which facilitate exit from the nucleus, as well as the production of different isoforms, endowing multicellular organisms with spatial and temporal gene expression diversity. Scientists of the AlternativeEnds project, funded by the European Research Council, are interested to understand the underlying mechanism implicated in RNA cleavage and termination. Project activities will provide fundamental insight into alternative gene expression and offer the possibility of manipulating cleavage site selection for therapeutic purposes.

Objective

The human genome contains only ~20.000 genes, however, most of them encode multiple transcripts resulting from alternative promoter usage, splicing, and 3’ end selection. Gene 3’ ends can be defined by the positions of RNA 3’ cleavage, or the location where RNA polymerase II terminates transcription. Alternative 3’ ends determine the properties of the encoded protein: typically its abundance, but sometimes also domain structure – as for immunoglobulin M heavy chain which is membrane-bound or secreted depending on the 3’ cleavage site. Widespread changes in 3’ end usage are characteristic of many processes e.g. differentiation and cancer like neuroblastoma. We do not understand what drives this selectivity.
In this research project I will answer the fundamental question of how the location and timing of RNA polymerase II entering into termination mode impacts on the choice of the alternative cleavage and polyadenylation site (Aim 1). I will use biochemical and genetic approaches to elucidate the sequence determinant of alternative cleavage and termination (Aim 2), and investigate sequence-independent components of alternative termination (Aim 3).
I recently pioneered the measurement of 3’ cleavage positions together with locations of transcription termination by a novel transcriptomic method. I will apply this method to investigate the timing of changes in cleavage and termination relative to each other on an averaged cell population level, and use a new technique to test this for single molecules. I will also determine the baseline for cleavage site selection utilizing a newly developed in vitro system. Combining those unique integrative and separation-of-function approaches will yield a comprehensive view of alternative gene end regulation.
Ultimately, understanding the complex crosstalk between RNA cleavage and transcription termination in alternative 3’ end selection will enable the manipulation of this process e.g. to alleviate diseases such as neuroblastoma.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2021-STG

See all projects funded under this call

Host institution

UNIWERSYTET IM. ADAMA MICKIEWICZA WPOZNANIU
Net EU contribution
€ 1 444 600,00
Address
ULICA HENRYKA WIENIAWSKIEGO 1
61 712 Poznan
Poland
Region
Makroregion północno-zachodni Wielkopolskie Miasto Poznań
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 444 600,00

Beneficiaries (2)